FDMT fundamentals
An in-depth look to 4D Molecular Therapeutics, Inc. operating, investing, and financing activities
FDMT free cash flow for Q3 23 is -1.58 M USD. For 2023, FDMT free cash flow was -78.56 M USD and operating cash flow was -75.79 M USD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM